Description: Incresync 25/15 mg Tablets are a combination medication used to improve blood sugar control in adults with type 2 diabetes. The active ingredients, alogliptin and pioglitazone, work together to regulate insulin levels and glucose production, helping to manage diabetes more effectively.
Ingredients:
-
Active Ingredients:
- 25 mg of Alogliptin
- 15 mg of Pioglitazone
-
Other Ingredients:
- [List any excipients or additional components, such as lactose monohydrate, microcrystalline cellulose, hydroxypropyl cellulose, etc.]
Usage Instructions:
-
Dosage: The usual starting dose is one tablet (25/15 mg) taken once daily.
-
Frequency: Once daily.
-
Special Considerations: Tablets should be taken whole with or without food. Do not split, chew, or crush the tablets.
Benefits:
- Combines two diabetes medications for improved blood sugar control.
- Alogliptin increases insulin release and decreases glucose production in the liver.
- Pioglitazone increases insulin sensitivity in the body’s cells, enhancing glucose uptake.
Precautions:
-
Contraindications: Do not use if there is a history of severe heart failure, bladder cancer, or allergic reactions to alogliptin, pioglitazone, or any other ingredients in the tablet.
-
Side Effects: Common side effects may include upper respiratory tract infection, headache, sinusitis, and muscle pain. Serious side effects may include heart failure, liver problems, and bladder cancer.
-
Warnings: Monitor liver function regularly. Use with caution in patients with a history of heart failure. Not recommended for use during pregnancy or breastfeeding unless clearly needed.
Storage Instructions:
- Store at room temperature (20°C to 25°C or 68°F to 77°F).
- Keep in a dry place, away from direct light and moisture.
- Keep out of reach of children.
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
